Glucocorticoid-Induced Leucine Zipper Protein Controls Macropinocytosis in Dendritic Cells

Joseph Calmette1, Matthieu Bertrand1, Mathias Vétillard1

  • 1UMR996-Inflammation, Chimiokines et Immunopathologie, INSERM, Université Paris-Sud, Université Paris-Saclay, Clamart 92140, France.

Insights

Glucocorticoid-induced leucine zipper protein (GILZ) inhibits macropinocytosis in dendritic cells (DCs), impacting antigen cross-presentation. This regulation fine-tunes immune responses by controlling Ag uptake mechanisms.

Area of Science:

  • Immunology
  • Cell Biology

Background:

  • Dendritic cells (DCs) are crucial for T cell activation through antigen (Ag) sampling.
  • DCs utilize macropinocytosis, receptor-mediated endocytosis, and phagocytosis for Ag uptake.

Purpose of the Study:

  • To investigate the regulatory mechanisms of Ag uptake by DCs.
  • To determine the role of GILZ in controlling Ag sampling by DCs.

Main Methods:

  • In vitro and in vivo studies using LPS-stimulated DCs.
  • Analysis of Ag uptake pathways, including macropinocytosis and phagocytosis.
  • Assessment of GILZ expression and its effect on p38 MAPK phosphorylation.

Main Results:

  • GILZ selectively inhibits macropinocytosis, not phagocytosis, in immature and activated DCs.
  • GILZ-mediated inhibition of Ag uptake is specific to the CD8α+ DC subset in vivo.
  • GILZ limits p38 MAPK phosphorylation in activated DCs, suggesting a mechanism for macropinocytosis control.
  • Modulation of Ag uptake by GILZ affects CD8 T cell cross-presentation but not CD4 T cell presentation.

Conclusions:

  • GILZ acts as an endogenous inhibitor of macropinocytosis in DCs.
  • GILZ fine-tunes Ag cross-presentation efficiency by regulating DC Ag uptake.